<DOC>
	<DOCNO>NCT01427582</DOCNO>
	<brief_summary>The YONDELIS ( trabectedin ) Single Patient Compassionate Use /Expanded Access program provide patient advanced soft tissue sarcoma , qualify ongoing clinical trial YONDELIS ( trabectedin ) , access investigational treatment .</brief_summary>
	<brief_title>YONDELIS ( Trabectedin ) Single Patient Compassionate Use / Expanded Access</brief_title>
	<detailed_description>The single patient treatment instruction use intend single patient advance soft tissue sarcoma . The patient treat YONDELIS® ( trabectedin ) i.v . formulation dose 1.5 mg/m2 i.v . 24 hour Day 1 every 21 day , provide he/she fulfills eligibility criterion . The patient may continue receive therapy evidence disease progression unacceptable toxicity . Safety evaluate serious adverse event report . Disease assessments occur accord institutional practice .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Trabectedin</mesh_term>
	<criteria>1 . Signed informed consent . 2 . 18 yearsofage old . 3 . Unresectable , advanced metastatic , histologically proven soft tissue sarcoma . 4 . Recovery toxic effect prior therapy NCI CTC Grade 1 better . 5 . Hematologic variable : Hemoglobin ≥9 g/dL ANC ≥1,500/μL Platelet count ≥100,000/μL 6 . Serum creatinine ≤ upper limit normal ( ULN ) 7 . Hepatic function variable : Total bilirubin ≤ ULN Total alkaline phosphatase ≤ ULN , &gt; ULN , alkaline phosphatase liver fraction 5'nucleotidase must ≤ ULN . AST ( serum aspartate transaminase [ SGOT ] ) ALT ( serum alanine transaminase [ SGPT ] ) must ≤ 2.5xULN Albumin ≥2.5 g/dL 1 . Pregnant breastfeed woman , patient ( male female ) employ adequate contraception . Acceptable mean birth control include IUD , oral contraceptive , subdermal implant , condom contraceptive sponge suppository . 2 . Less 4 week last dose systemic cytotoxic therapy , radiation therapy , therapy investigational agent 3 . Active viral hepatitis chronic liver disease 4 . Unstable cardiac condition , include congestive heart failure angina pectoris , myocardial infarction within 1 year enrollment , uncontrolled arterial hypertension arrhythmias 5 . Active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>